Surgical resection of pancreatic head cancer

What is the optimal extent of surgery?

Research output: Contribution to journalShort surveyResearchpeer-review

14 Citations (Scopus)

Abstract

Extent of surgery should depend on curability. Improvements in surgical techniques have resulted in surgeons seeking to perform more radical surgery. To date, five randomized controlled trials (RCT) have analyzed the benefits of extended lymphadenectomy for pancreatic head cancer, but none has shown that extended lymphadenectomy enhances patient survival. As most patients with pancreatic cancer have microscopic, locally advanced disease that cannot be cured by surgery alone, local tumor control by extended lymphadenectomy cannot overcome the negative aspects of pre-existing lymph node metastasis. The most important factor improving overall survival following pancreatoduodenectomy in patients with pancreatic head cancer is proper systemic control of the disease rather than extensive local control. The long-term survival outcomes following adjuvant treatment in a large multi-center RCT suggest the need for aggressive systemic treatment. More attention must be paid to the benefits of adjuvant treatment, not only focusing on technical R0 resection. Surgical strategies for patients with pancreatic head cancer require more flexibility, with extent of surgery customized to individual patients, depending on tumor location and disease severity.

Original languageEnglish
Pages (from-to)259-265
Number of pages7
JournalCancer Letters
Volume382
Issue number2
DOIs
StatePublished - 28 Nov 2016

Fingerprint

Head and Neck Neoplasms
Pancreatic Neoplasms
Lymph Node Excision
Survival
Randomized Controlled Trials
Pancreaticoduodenectomy
Neoplasms
Therapeutics
Lymph Nodes
Neoplasm Metastasis

Keywords

  • Extended
  • Lymph node
  • Lymphadenectomy
  • Pancreatic cancer
  • Survival

Cite this

@article{5fb409fa1a354f5ea9ea624dd1b36721,
title = "Surgical resection of pancreatic head cancer: What is the optimal extent of surgery?",
abstract = "Extent of surgery should depend on curability. Improvements in surgical techniques have resulted in surgeons seeking to perform more radical surgery. To date, five randomized controlled trials (RCT) have analyzed the benefits of extended lymphadenectomy for pancreatic head cancer, but none has shown that extended lymphadenectomy enhances patient survival. As most patients with pancreatic cancer have microscopic, locally advanced disease that cannot be cured by surgery alone, local tumor control by extended lymphadenectomy cannot overcome the negative aspects of pre-existing lymph node metastasis. The most important factor improving overall survival following pancreatoduodenectomy in patients with pancreatic head cancer is proper systemic control of the disease rather than extensive local control. The long-term survival outcomes following adjuvant treatment in a large multi-center RCT suggest the need for aggressive systemic treatment. More attention must be paid to the benefits of adjuvant treatment, not only focusing on technical R0 resection. Surgical strategies for patients with pancreatic head cancer require more flexibility, with extent of surgery customized to individual patients, depending on tumor location and disease severity.",
keywords = "Extended, Lymph node, Lymphadenectomy, Pancreatic cancer, Survival",
author = "Kang, {Mee Joo} and Jin-Young Jang and Kim, {Sun Whe}",
year = "2016",
month = "11",
day = "28",
doi = "10.1016/j.canlet.2016.01.042",
language = "English",
volume = "382",
pages = "259--265",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

Surgical resection of pancreatic head cancer : What is the optimal extent of surgery? / Kang, Mee Joo; Jang, Jin-Young; Kim, Sun Whe.

In: Cancer Letters, Vol. 382, No. 2, 28.11.2016, p. 259-265.

Research output: Contribution to journalShort surveyResearchpeer-review

TY - JOUR

T1 - Surgical resection of pancreatic head cancer

T2 - What is the optimal extent of surgery?

AU - Kang, Mee Joo

AU - Jang, Jin-Young

AU - Kim, Sun Whe

PY - 2016/11/28

Y1 - 2016/11/28

N2 - Extent of surgery should depend on curability. Improvements in surgical techniques have resulted in surgeons seeking to perform more radical surgery. To date, five randomized controlled trials (RCT) have analyzed the benefits of extended lymphadenectomy for pancreatic head cancer, but none has shown that extended lymphadenectomy enhances patient survival. As most patients with pancreatic cancer have microscopic, locally advanced disease that cannot be cured by surgery alone, local tumor control by extended lymphadenectomy cannot overcome the negative aspects of pre-existing lymph node metastasis. The most important factor improving overall survival following pancreatoduodenectomy in patients with pancreatic head cancer is proper systemic control of the disease rather than extensive local control. The long-term survival outcomes following adjuvant treatment in a large multi-center RCT suggest the need for aggressive systemic treatment. More attention must be paid to the benefits of adjuvant treatment, not only focusing on technical R0 resection. Surgical strategies for patients with pancreatic head cancer require more flexibility, with extent of surgery customized to individual patients, depending on tumor location and disease severity.

AB - Extent of surgery should depend on curability. Improvements in surgical techniques have resulted in surgeons seeking to perform more radical surgery. To date, five randomized controlled trials (RCT) have analyzed the benefits of extended lymphadenectomy for pancreatic head cancer, but none has shown that extended lymphadenectomy enhances patient survival. As most patients with pancreatic cancer have microscopic, locally advanced disease that cannot be cured by surgery alone, local tumor control by extended lymphadenectomy cannot overcome the negative aspects of pre-existing lymph node metastasis. The most important factor improving overall survival following pancreatoduodenectomy in patients with pancreatic head cancer is proper systemic control of the disease rather than extensive local control. The long-term survival outcomes following adjuvant treatment in a large multi-center RCT suggest the need for aggressive systemic treatment. More attention must be paid to the benefits of adjuvant treatment, not only focusing on technical R0 resection. Surgical strategies for patients with pancreatic head cancer require more flexibility, with extent of surgery customized to individual patients, depending on tumor location and disease severity.

KW - Extended

KW - Lymph node

KW - Lymphadenectomy

KW - Pancreatic cancer

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=84958206452&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2016.01.042

DO - 10.1016/j.canlet.2016.01.042

M3 - Short survey

VL - 382

SP - 259

EP - 265

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -